T. Rowe Price Associates’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-22,550
Closed -$49K 3065
2024
Q3
$49K Hold
22,550
﹤0.01% 2929
2024
Q2
$117K Hold
22,550
﹤0.01% 2726
2024
Q1
$121K Hold
22,550
﹤0.01% 2746
2023
Q4
$176K Hold
22,550
﹤0.01% 2584
2023
Q3
$90K Hold
22,550
﹤0.01% 2684
2023
Q2
$72K Hold
22,550
﹤0.01% 2749
2023
Q1
$61K Buy
22,550
+10,400
+86% +$28.1K ﹤0.01% 2764
2022
Q4
$44K Buy
+12,150
New +$44K ﹤0.01% 2827
2022
Q3
Sell
-8,092
Closed -$78K 3045
2022
Q2
$78K Buy
8,092
+4
+0% +$39 ﹤0.01% 2801
2022
Q1
$96K Sell
8,088
-2,040
-20% -$24.2K ﹤0.01% 2845
2021
Q4
$330K Buy
10,128
+5,220
+106% +$170K ﹤0.01% 2558
2021
Q3
$219K Buy
+4,908
New +$219K ﹤0.01% 2686
2021
Q1
Sell
-4,759
Closed -$516K 2872
2020
Q4
$516K Buy
4,759
+629
+15% +$68.2K ﹤0.01% 2222
2020
Q3
$365K Buy
4,130
+1,880
+84% +$166K ﹤0.01% 2214
2020
Q2
$240K Sell
2,250
-6,455
-74% -$689K ﹤0.01% 2316
2020
Q1
$516K Buy
8,705
+4,455
+105% +$264K ﹤0.01% 1977
2019
Q4
$294K Sell
4,250
-3,466
-45% -$240K ﹤0.01% 2316
2019
Q3
$801K Sell
7,716
-6,527
-46% -$678K ﹤0.01% 1903
2019
Q2
$1.32M Sell
14,243
-1,485
-9% -$138K ﹤0.01% 1726
2019
Q1
$1.44M Sell
15,728
-15,263
-49% -$1.39M ﹤0.01% 1700
2018
Q4
$1.73M Sell
30,991
-1,730
-5% -$96.4K ﹤0.01% 1601
2018
Q3
$3.9M Sell
32,721
-27
-0.1% -$3.22K ﹤0.01% 1484
2018
Q2
$3.34M Buy
32,748
+20
+0.1% +$2.04K ﹤0.01% 1487
2018
Q1
$4.25M Buy
32,728
+1,732
+6% +$225K ﹤0.01% 1449
2017
Q4
$3.02M Buy
30,996
+130
+0.4% +$12.6K ﹤0.01% 1479
2017
Q3
$4.54M Buy
+30,866
New +$4.54M ﹤0.01% 1435